Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1179-1197
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1179
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1179
Name | Components | Interpretation | Advantages | Disadvantages |
Ranson Score | Total of 11 variables to be used | Predicts severity of AP and mortality on admission and 48 h of admission | High prognostic accuracy (AUC 0.81) compared to APACHE II (AUC 0.80), BISAP (AUC 0.79) and CTSI (AUC 0.80) in prediction of AP severity[36] | Low sensitivity (66%) when used before 48 h compared to APACHE II (84%), Glasgow score (78%), HAPS (71%) |
On admission: (1) WBC > 16 × 109/L; (2) Age > 55 yr; (3) Glucose > 10 mmol/L (200 mg/dL); (4) AST > 250 IU/L; and (5) LDH > 350 IU/L | Severity of AP: < 3: Unlikely SAP; ≥ 3: Likely SAP | High prognostic accuracy (AUC 0.87) in prediction of mortality, similar to CTSI (AUC 0.87), slightly worse compared to APACHE II (AUC 0.91)[36] | Higher sensitivity than BISAP (54%)[38] | |
48-h compared to admission: (1) Hct drop > 10%; (2) BUN increase > 1.79 mmol/L (5 mg/dL); (3) Calcium < 2 mmol/L (8 mg/dL); (4) Arterial PaO2 < 60 mmHg; (5) Base deficit > 4 mg/dL; and (6) Fluid needs > 6 L within 48 h | Mortality risk: 0-3: 1%; 3-4: 15%; 5-6: 40%; ≥ 7: Nearly 100% | |||
The Glasgow-Imrie score | 8 variables calculated at 48 h of admission: (1) PaO2 < 59.3 mmHg; (2) Age > 55 yr; (3) WBC > 15 × 109/L; (4) Calcium < 2 mmol/L (8 mg/dL); (5) BUN > 44.8 mg/dL (serum urea > 16 mmol/L); (6) LDH > 600 IU/L; (7) Albumin < 32 g/L (3.2 g/dL); and (8) Glucose > 10 mmol/L (180 mg/dL) | Predicts risk of SAP | Has decent sensitivity (78%) and specificity (82%) when used even within/before 48 h | Limited prognostic accuracy (< 70%) and positive predictive value (70%) |
Severity of AP: < 3: Unlikely SAP; ≥ 3: Likely SAP | High NPV in prediction for mortality (range 86%-100%)[39] | Unable to provide timely assessment as patients are scored only at 48 h (original design of scoring system) | ||
Risk of SAP in original study: 0: 7%; 1: 6%; 2: 16%; 3: 20%; 4: 61%; 5: 55%; 6: 100%; 7: 0%; 8: 100% | Low PPV for prediction of mortality (range 18%-66%)[39] | |||
APACHE II | List of 15 variables used1: (1) History of severe organ failure/immunocompromised state e.g. Heart failure Class IV, cirrhosis, chronic lung disease, dialysis-dependent: (2) Age; (3) Temperature; (4) Mean arterial pressure; (5) Heart rate; (6) Respiratory rate; (7) FiO2; (8) Glasgow coma scale; (9) pH; (10) Sodium; (11) Potassium; (12) Creatinine; (13) Acute renal failure; (14) Hct; and (15) WBC count | Original use: Predicts mortality in ICU; Validated studies: Predicts severity and risk of mortality in AP | Can be used at any timepoint during the course of disease | Cumbersome to use in view of long list of variables required |
Interpretation2[32]: (1) < 8: Low risk of SAP, low risk of mortality; and (2) ≥ 8: High risk of SAP, high risk of mortality | Has decent sensitivity (71%) and specificity (80%) for predicting SAP, and has high sensitivity (92%) with slightly lower specificity (79%) in predicting mortality[36] | Low specificity compared to Ranson score at 48 h (62% vs 93%) at 48 h of admission[38] | ||
CTSI | Consists of 2 components | Predicts severity of AP (Sum of Balthazar score and extent of pancreatic necrosis): 0-3: Mild AP; 4-6: Moderate AP; 7-10: SAP | Acceptable sensitivity (81%) and specificity (82%) in prediction of SAP[36] | While able to predict SAP, score did not correlate with subsequent development of organ failure and extra-pancreatic complications |
Balthazar score (grading of pancreatitis): A (0): Normal pancreas; B (1): Enlargement of pancreas; C (2): Inflammatory changes in pancreas and peripancreatic fat; D (3): Ill-defined single peripancreatic fluid collection; and E (4): ≥ 2 poorly defined peripancreatic fluid collection | Patients with > 30% necrosis have similar morbidity and mortality (additional scoring for > 50% is not useful)[29] | |||
Extent of pancreatic necrosis: None: 0; ≤ 30%: 2; > 30%-50%: 4; > 50%: 6 | Requires the use of CT, and ideal time for imaging is ≥ 72 h from onset of symptoms | |||
Modified CTSI (MCTSI) | Consists of 3 components: | Predicts severity of AP: 0-2: Mild AP; 4-6: Moderate AP; 8-10: SAP | Easier to calculate compared to CTSI | CT assessment of severity may not correlate with incidence of organ failure and risk of infection[30] |
Pancreatic inflammation: 0: Normal pancreas; 2: Intrinsic pancreatic abnormalities with/without inflammatory changes in peripancreatic fat; 4: Pancreatic/peripancreatic fluid collection/peripancreatic fat necrosis | Higher interobserver reliability compared to CTSI | Requires the use of CT, and ideal time for imaging is ≥ 72 h from onset of symptoms | ||
Pancreatic necrosis: 0: None; 2: ≤ 30%; 4: > 30% | Comparable to CTSI in prognostic accuracy for severity of AP; MCTSI (AUC 0.83, sensitivity 88%, specificity 80%); CTSI (AUC 0.80, sensitivity 81%, specificity 82%)[30] | |||
Extra-pancreatic complications: 2: ≥ 1 of pleural effusion, ascites, vascular complications, parenchymal complications and/or gastrointestinal involvement | ||||
BISAP | List of 5 variables used: (1) BUN > 25 mg/dL; (2) Impaired mental status; (3) SIRS; (4) Age > 60 yr; and (5) Pleural effusion | Predicts mortality in AP. Mortality risk in original study (within 24 h in patients without evidence of organ failure)[28]: 0: 0.1%; 1: 0.4%; 2: 1.6%; 3: 3.6%; 4: 7.4%; 5: 9.5% | Easy to use scoring system which can be used within 24 h of admission | Potential underscoring of patients if done within 24 h as pleural effusion may be a late development |
Varying cut-offs proposed for mortality[37]: ≥ 2: AUC 0.82, sensitivity 81%, specificity 70%; ≥ 3: AUC 0.87, sensitivity 56%, specificity 91% | Low sensitivity in prediction of SAP | |||
Varying cut-offs proposed for SAP risk: ≥ 2: AUC 0.88, sensitivity 63%, specificity 82%; ≥ 3: AUC 0.87, sensitivity 51%, specificity 91% | Inferior to Ranson score in prediction of mortality[37] | |||
HAPS | List of 3 variables: (1) Absence of rebound tenderness/guarding; (2) Normal Hct (males: ≤ 43.0%, females ≤ 39.6%); and (3) Normal creatinine ≤ 176.8 μmol/L (2 mg/dL) | Predicts risk of mild AP | Easy and quick to use scoring system to predict risk of mild AP to determine disposition | May miss out cases which appear to be mild AP but progress to moderately severe or severe if patients present early |
Interpretation: 0: Predicts no pancreatic necrosis, need for dialysis, mechanical ventilation, or fatal outcome (PPV 98%, NPV 18%, specificity 97%, sensitivity 28%)[33]; ≥ 1: Unable to exclude risk of above | Unable to predict risk of SAP | |||
SOFA | List of 5 variables used1, within 24 h of admission (graded 0-4 for each variable): (1) Glasgow coma scale; (2) Mean arterial pressure, or need for vasoactive agents; (3) PaO2/FiO2; (4) Platelet count; and (5) Total bilirubin | Original use: Predicts mortality in ICU | Relatively easy to use scoring system compared to APACHE II, Ranson score and Glasgow-Imrie score | Underperforms compared to Ranson score (NPV for SAP: 98.0%, NPV for ICU admission: 100%, NPV for mortality: 100%) and Glasgow-Imrie score (NPV for SAP: 95.4%, NPV for ICU admission: 99.3%, NPV for mortality: 99.5%) when scored at 48 h[35] |
Validated studies[35,42]: Predicts risk of SAP, ICU admission and mortality in AP | High NPV which can screen out mild disease or need for ICU admission at onset within 24 h of admission | |||
Cut-off score of ≥ 7 to predict SAP, ICU admission and mortality: (1) SAP: AUC 0.966, PPV: 84.6%, NPV: 89.1%, sensitivity: 13.6%, specificity: 99.7%; (2) ICU admission: AUC 0.943, PPV: 61.5%, NPV: 98.1%, sensitivity 40.0%, specificity: 99.2%; and (3) Mortality: AUC: 0.968, PPV: 46.2%, NPV: 99.1%, sensitivity: 50.0%, specificity: 98.9% |
- Citation: Chan KS, Shelat VG. Diagnosis, severity stratification and management of adult acute pancreatitis–current evidence and controversies. World J Gastrointest Surg 2022; 14(11): 1179-1197
- URL: https://www.wjgnet.com/1948-9366/full/v14/i11/1179.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i11.1179